Mark Orlowski

465 total citations
12 papers, 340 citations indexed

About

Mark Orlowski is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Mark Orlowski has authored 12 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Mark Orlowski's work include Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Mark Orlowski is often cited by papers focused on Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Mark Orlowski collaborates with scholars based in United States and Canada. Mark Orlowski's co-authors include Janina Orłowska, Z Albert, Boris Feld, Anita Y. M. Howe, Ariamala Gopalsamy, John W. Ellingboe, Kaapjoo Park, Juliette O’Connell, Tarek S. Mansour and Jonathan D. Bloom and has published in prestigious journals such as Journal of Medicinal Chemistry, Virology and Thrombosis and Haemostasis.

In The Last Decade

Mark Orlowski

12 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Orlowski United States 8 139 89 81 81 78 12 340
Ma’an Amad Canada 7 92 0.7× 88 1.0× 237 2.9× 75 0.9× 45 0.6× 8 483
Robert G. Gentles United States 17 100 0.7× 86 1.0× 345 4.3× 146 1.8× 221 2.8× 36 669
Francine Liard Canada 8 65 0.5× 70 0.8× 100 1.2× 62 0.8× 70 0.9× 13 286
John K. Pratt United States 15 186 1.3× 134 1.5× 207 2.6× 103 1.3× 311 4.0× 23 711
Juliang Zhu United States 11 47 0.3× 80 0.9× 117 1.4× 71 0.9× 163 2.1× 16 382
Joseph F. Leone United States 11 56 0.4× 101 1.1× 149 1.8× 48 0.6× 90 1.2× 16 324
Roger A. Fujimoto Switzerland 9 77 0.6× 18 0.2× 155 1.9× 50 0.6× 157 2.0× 12 463
Harry B. Marr United States 10 56 0.4× 118 1.3× 201 2.5× 84 1.0× 79 1.0× 13 554
Cliff C. Cheng United States 10 20 0.1× 24 0.3× 204 2.5× 31 0.4× 74 0.9× 13 304
Déborah Harrus France 11 63 0.5× 36 0.4× 184 2.3× 45 0.6× 43 0.6× 14 297

Countries citing papers authored by Mark Orlowski

Since Specialization
Citations

This map shows the geographic impact of Mark Orlowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Orlowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Orlowski more than expected).

Fields of papers citing papers by Mark Orlowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Orlowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Orlowski. The network helps show where Mark Orlowski may publish in the future.

Co-authorship network of co-authors of Mark Orlowski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Orlowski. A scholar is included among the top collaborators of Mark Orlowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Orlowski. Mark Orlowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nittoli, Thomas, Kevin Curran, Martin DiGrandi, et al.. (2007). Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase.. Journal of Medicinal Chemistry. 50(24). 6290–6290. 3 indexed citations
2.
Nittoli, Thomas, Kevin J. Curran, Martin DiGrandi, et al.. (2007). Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase. Journal of Medicinal Chemistry. 50(9). 2108–2116. 42 indexed citations
3.
Gopalsamy, Ariamala, Mengxiao Shi, Kaapjoo Park, et al.. (2006). Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 16(9). 2532–2534. 15 indexed citations
4.
5.
Gopalsamy, Ariamala, Rajiv Chopra, Mengxiao Shi, et al.. (2006). Discovery of Proline Sulfonamides as Potent and Selective Hepatitis C Virus NS5b Polymerase Inhibitors. Evidence for a New NS5b Polymerase Binding Site. Journal of Medicinal Chemistry. 49(11). 3052–3055. 46 indexed citations
6.
Gopalsamy, Ariamala, Kaapjoo Park, John W. Ellingboe, et al.. (2005). Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 16(2). 457–460. 33 indexed citations
7.
Gopalsamy, Ariamala, John W. Ellingboe, Girija Krishnamurthy, et al.. (2004). Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 14(16). 4221–4224. 9 indexed citations
8.
Gopalsamy, Ariamala, Kaapjoo Park, John W. Ellingboe, et al.. (2004). Discovery of Pyrano[3,4-b]indoles as Potent and Selective HCV NS5B Polymerase Inhibitors. Journal of Medicinal Chemistry. 47(26). 6603–6608. 80 indexed citations
9.
Amin, Anthony A., Stéphane Olland, Mark Orlowski, et al.. (2003). Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase. Virology. 313(1). 158–169. 9 indexed citations
10.
Orlowski, Mark, et al.. (1968). The Activity of Plasma, Serum, Thrombin, and Plasmin toward Synthetic Trypsin Substrates. Thrombosis and Haemostasis. 19(01/02). 99–106. 2 indexed citations
11.
Albert, Z, et al.. (1966). Studies on gamma-glutamyl transpeptidase activity and its histochemical localization in the central nervous system of man and different animal species.. PubMed. 25(5). 312–20. 99 indexed citations
12.
Reagan, Reginald L., et al.. (1953). Response of Young Dogs to West Nile Virus. Experimental Biology and Medicine. 82(2). 261–262. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ma’an Amad Breakdown of academic impact, for papers by Robert G. Gentles Breakdown of academic impact, for papers by Francine Liard Breakdown of academic impact, for papers by John K. Pratt Breakdown of academic impact, for papers by Juliang Zhu Breakdown of academic impact, for papers by Joseph F. Leone Breakdown of academic impact, for papers by Roger A. Fujimoto Breakdown of academic impact, for papers by Harry B. Marr Breakdown of academic impact, for papers by Cliff C. Cheng Breakdown of academic impact, for papers by Déborah Harrus
Rankless by CCL
2026